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Neurons expressing neuropeptide orexins (hypocretins) in the lateral hypothalamus (LH)
and serotonergic neurons in the dorsal raphe nucleus (DR) both play important roles
in the regulation of sleep/wakefulness states, and show similar firing patterns across
sleep/wakefulness states. Orexin neurons send excitatory projections to serotonergic
neurons in the DR, which express both subtypes of orexin receptors (Mieda et al.,
2011), while serotonin (5-HT) potently inhibits orexin neurons through activation of
5HT1A receptors (5HT1ARs). In this study, we examined the physiological importance of
serotonergic inhibitory regulation of orexin neurons by studying the phenotypes of mice
lacking the 5HT1A receptor gene (Htr1a) specifically in orexin neurons (ox5HT1ARKO
mice). ox5HT1ARKO mice exhibited longer NREM sleep time along with decreased
wakefulness time in the later phase of the dark period. We also found that restraint
stress induced a larger impact on REM sleep architecture in ox5HT1ARKO mice than
in controls, with a larger delayed increase in REM sleep amount as compared with
that in controls, indicating abnormality of REM sleep homeostasis in the mutants.
These results suggest that 5HT1ARs in orexin neurons are essential in the regulation
of sleep/wakefulness states, and that serotonergic regulation of orexin neurons plays a
crucial role in the appropriate control of orexinergic tone to maintain normal sleep/wake
architecture.
Keywords: sleep, wakefulness, orexin, serotonin, stress
INTRODUCTION
Orexin A and orexin B, also known as hypocretin-1 and hypocretin-2, respectively, are important
regulators of sleep/wakefulness states (Sakurai, 2007, 2014). Orexin/hypocretin-producing neurons
(orexin neurons) are located in the lateral hypothalamus (LH) and send axonal projections
widely to the entire brain, except the cerebellum, with especially abundant projections to the
monoaminergic/cholinergic nuclei in the hypothalamus and brainstem regions (Peyron et al., 1998;
Date et al., 1999; Nambu et al., 1999). The actions of orexins are mediated via two G-protein
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coupled receptors (GPCRs), orexin 1 receptor (OX1R) and
orexin 2 receptor (OX2R) (Sakurai et al., 1998). OX1R and
OX2R mRNAs exhibit a markedly different and basically
complementary distribution, suggesting that these receptors have
distinct physiological roles through different neuronal pathways
(Sakurai, 2007). The importance of orexins in the maintenance
of consolidated sleep/wakefulness states is highlighted by the
finding that the sleep disorder narcolepsy is caused by orexin
deficiency in several mammalian species, including mice, dogs,
and humans (Peyron et al., 1998; Chemelli et al., 1999; Lin
et al., 1999; Thannickal et al., 2000). Recent investigations have
suggested additional functions of orexins in the regulation of
emotions, energy homeostasis, reward systems, drug addiction,
and autonomic function (Sakurai, 2014; Soya et al., 2017).
Elucidation of the regulatory mechanisms of orexin neurons
is important for understanding the physiological mechanisms
of sleep/wakefulness control and the roles of orexin neurons in
these functions. Orexin neurons receive innervations from many
brain regions, including the limbic system, preoptic area, and
monoaminergic neurons (Sakurai et al., 2005; Yoshida et al., 2006;
Saito et al., 2018). Among the factors that influence the activity of
orexin neurons, serotonin (5-HT) was shown to strongly inhibit
most orexin neurons through 5HT1A receptors (5HT1ARs)
(Muraki et al., 2004; Tabuchi et al., 2014; Saito et al., 2018). At
the same time, GABAergic neurons in the preoptic area that send
direct inhibitory projections to orexin neurons are inhibited by 5-
HT (Saito et al., 2018), implying that the serotonergic regulation
of orexin neurons is complex. A retrograde tracing study of DR
5-HT neurons using rabies virus also showed that orexin neurons
send innervations to serotonergic neurons in the DR, suggesting a
close relationship between orexin and 5-HT (Pollak Dorocic et al.,
2014). However, the function of direct serotonergic regulation of
orexin neurons has remained unclear.
In the present study, we generated mice with a selective
deletion of the 5HT1A receptor gene (Htr1a) specifically in orexin
neurons (Htr1af /f ;orexin-Cre mice, referred to as ox5HT1ARKO
mice) to study the consequences of deletion of Htr1a in orexin
neurons in mice to remove the serotonergic regulation of orexin
neurons. ox5HT1ARKO mice showed shorter wakefulness time
during the later phase of the dark period as compared with wild
type and control mice. Alteration in the architecture of REM
sleep induced by acute restraint stress was more prominent in
ox5HT1ARKO mice than in controls. These observations suggest
that serotonergic regulation of orexin neurons plays an important
role in normal maintenance of wakefulness and homeostasis of
REM sleep amount.
MATERIALS AND METHODS
Animals
All experimental procedures involving animals were approved
by the Animal Experiment and Use Committee of Kanazawa
University (AP-132649) and the University of Tsukuba (18-173),
and thus were in accordance with NIH guidelines. Htr1af /f
mice with inclusion of lox-P sequences in the htr1a gene
were generated by homologous recombination in C57BL/6N
embryonic stem cells and implantation in 8-cell-stage embryos
(ICR). A targeting vector was designed to flank the coding region
of the Htr1a gene by lox-P sites (Figure 1A). Chimeric mice
were crossed to C57BL/6J females (Jackson Labs). The pgk-Neo
cassette was deleted by crossing them with FLP66 mice, which
had been backcrossed to C57BL/6J mice more than 10 times.
Initially, F1 hybrids from heterozygous × heterozygous mating
were generated. We backcrossed them to C57BL/6J mice more
than eight times. Genotypes were determined by PCR of mouse
tail DNA.
Orexin-Cre transgenic mice (Matsuki et al., 2009) were crossed
with wild type C57BL6/J mice more than 10 times. Orexin-
Cre mice were mated with Htr1af /f mice, and a breeding
colony for producing orexin-Cre; Htr1af /f was maintained by
mating Ht1arf /f with orexin/Cre; Ht1arf /+ mice. We used
littermates as controls, and all experiments were performed in
a C57BL/6J background. We confirmed that wild type mice,
orexin-Cre transgenic mice, Ht1ar f /+;orexin-Cre, and Htr1af /f
(orexin-Cre-negative) mice all show the same sleep/wakefulness
characteristics (data not shown). In this study, Htr1af /f ;orexin-
Cre transgenic mice were used as orexin neuron-selective
5HT1AR knockout mice (ox5HT1ARKO), and Htr1af /+;orexin-
Cre transgenic mice were used as hetero orexin neuron-
selective 5HT1AR knockout mice (ox5HT1ARHKO). Their Htr1a
f /f ;orexin/Cre-negative littermates (control mice), which show
comparable sleep/wakefulness phenotypes to those of wild type
C57BL/6J mice, were used as controls. Mice were housed in a
temperature- and humidity-controlled, 12 h light/12 h dark room
(light on at 9:00), and access water and food ad libitum.
Electrophysiological Study
For electrophysiological analysis, ox5HT1ARKO mice were
mated with orexin-eGFP transgenic mice (Yamanaka et al., 2003)
(C57BL/6J background) to obtain ox5HT1ARKO;orexin-eGFP
mice, which express eGFP as a marker for detecting orexin
neurons, and their brain slice preparations were subjected to
patch-clamp recordings as previously described (Yamanaka et al.,
2003). In brief, brains were extracted and cooled in ice-cold
cutting solution consisting of (mM); 87 NaCl, 75 sucrose, 25
NaHCO3, 10 D(+)-glucose, 7 MgCl2, 2.5 KCl, 1.25 NaH2PO4,
and 0.5 CaCl2 bubbled with O2 95% and CO2 5%. Coronal
brain slices (250 µm thick) including LHA were prepared with
a vibratome (Leica, VT1200S) and incubated for 1 h at room
temperature in artificial cerebrospinal fluid (ACSF) containing
(mM); 125 NaCl, 26 NaHCO3, 10 D(+)-glucose, 2.5 KCl, 2 CaCl2,
and 1 MgSO4 bubbled with O2 95% and CO2 5%. The slices were
transferred to a recording chamber (RC-27L, Warner Instrument
Corp., Hamden, CT, United States) at room temperature on
a fluorescence microscope stage (BX51WI, Olympus, Tokyo,
Japan). Neurons that showed GFP fluorescence were used
for recordings. The fluorescence microscope was equipped
with an infrared camera (C-3077, Hamamatsu Photonics,
Hamamatsu, Japan) for infrared differential interference contrast
(IR-DIC) imaging and a CCD camera (JK-TU53H, Olympus) for
fluorescent imaging. Each image was displayed separately on a
monitor. Recordings were carried out with an Axopatch 700B
amplifier (Axon Instruments, Foster City, CA, United States)
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FIGURE 1 | Selective loss of 5HT1AR in orexin neurons in ox5HT1ARKO
mice. (A) Targeting strategy for making Htr1af/f mice. (B) Matched brain
sections from mice with various genotypes were double-stained with
anti-orexin (red) and anti-5HT1AR (green) serum. Double-positive cells are
shown by white arrowheads. Orexin neurons lacking 5HT1AR expression are
shown by arrows. WT, wild type; 5HT1ARf/f , Htr1af/f (orexin-Cre-negative);
ox5HT1ARHKO, Htr1af/+ (hetero) mice (orexin-Cre transgene-positive);
ox5HT1ARKO, Htr1af/f mice with orexin-Cre transgene. (C) Matched brain
sections containing the DR from ox5HT1ARKO and 5HT1ARf/f were doubly
stained with anti-TPH (red) and anti-5HT1AR (green) antibodies, showing
similar staining patterns. Left, control (5HT1ARf/f); Right ox5HT1ARKO, lower
panels show high power images of corresponding rectangle regions in upper
panels.
using a borosilicate pipette (GC150-10, Harvard Apparatus,
Holliston, MA, United States) prepared by a micropipette puller
(P-97, Sutter Instruments, Pangbourne, United Kingdom) and
filled with intracellular solution (4–10 M), consisting of (mM):
125 K-gluconate, 5 KCl, 1 MgCl2, 10 HEPES, 1.1 EGTA-Na3,
5 MgATP, 0.5 Na2GTP, pH7.3 with KOH. Osmolarity of the
solution was checked by a vapor pressure osmometer (model
5520, Wescor, Logan, UT, United States). The osmolarity of
the internal and external solutions was 280–290 and 320–
330 mOsm/l, respectively. The liquid junction potential of the
patch pipette and perfused extracellular solution was estimated
to be −16.2 mV and was applied to the data. The recording
pipette was under positive pressure while it was advanced toward
individual cells in the slice. Tight seals of 0.5–1.0 G were made
by negative pressure. The membrane patch was then ruptured by
suction. The series resistance during recording was 10–25 M
and was compensated. The reference electrode was an Ag–AgCl
pellet immersed in bath solution. Spontaneous action potentials
of GFP-expressing neurons were recorded with whole cell modes
at 30◦C kept by perfusion of preheated ACSF. During recordings,
cells were superfused with extracellular solution at a rate of
1.0–2.0 ml/min using a peristaltic pump (K.T. Lab, Japan) at room
temperature.
Histological Analyses
Mice were anesthetized with sodium pentobarbital and perfused
transcardially with phosphate-buffered saline (PBS) followed by
ice-cold 4% paraformaldehyde. Then, the perfused brains were
postfixed overnight in the same fixative buffer and placed in
30% sucrose buffer for 2 days. Cryostat sections (30-µm thick)
of the brains were incubated for 1 h in 0.1 M phosphate buffer
containing 1% bovine serum albumin and 0.25% Triton-X-100,
and incubated overnight at 4◦C with the primary antibodies. The
primary antibodies used were guinea pig anti-orexin (provided
by Prof. Watanabe of Hokkaido University, 1:1000); mouse
anti-TPH (Aldrich, T0678, 1:200), and rabbit anti-5HT1AR
(Acris, AP06769PU-N, 1:500). Secondary antibodies used were
Alexa 488-conjugated donkey anti-rabbit IgG (Invitrogen,
A21206, 1:800), Alexa 594-conjugated goat anti-guinea pig
IgG (Invitrogen, A11076, 1:800) and Alexa 647-conjugated
donkey anti-mouse IgG (Invitrogen, A31571, 1:800). Images were
obtained with a fluorescence microscopes (Keyence BZ-9000) or
confocal laser scanning microscopes (Leica SP8 and Olympus
FV10i).
Sleep Recordings
Male wild type mice (n = 8), ox5HT1ARKO mice (n = 6),
ox5HT1ARHKO mice (n = 3) and their weight- and age-matched
male control littermates: Htr1a f /f (orexin/Cre-negative) mice
(n = 9) were implanted with electrodes at 12 weeks of age for
EEG/EMG recording, as described previously (Hara et al., 2001).
An electrode for EEG and EMG recording was implanted in
the skull of each mouse. The three arms of the electrode for
EEG recording were placed approximately 2 mm anterior and
2 mm to the right, 2 mm posterior and 2 mm to the right, and
2 mm posterior and 2 mm to the left of the bregma. Stainless
steel wires for EMG recording were sutured to the neck muscles
of each mouse bilaterally, and each electrode was glued solidly
to the skull. After the recovery period, animals were moved to
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a recording cage placed in an electrically shielded and sound
attenuated room. A cable for signal output was connected to
the implanted electrode, and animals were allowed to move
freely. Mice are singly housed during recordings. Signals were
amplified through an amplifier (AB-611J, Nihon Koden, Tokyo)
and digitally recorded on a computer using EEG/EMG recording
software (Vital recorder, Kissei Comtec). Animals were housed
in a 12-h light/dark cycle and allowed to habituate to recording
conditions at least 7 days. Each mouse was then recorded for
three consecutive 24-h periods, beginning at lights-on at 09:00.
Lights were turned off at 21:00. Food and water were replenished
at 08:00, and mice were not otherwise disturbed in any way.
Averages of each time point on these three recording days were
used as raw data, and data from all individual animals used
in these studies were used to determine their sleep/wakefulness
characteristics.
Restraint Stress
Stress was applied through restraining mice with a sleeve of
nylon-mesh for 30 or 90 min until 21:00, just before the
start of the dark period. We folded a nylon mesh sheet
(150 mm × 200 mm) in two and hold a mouse in between folds
with clips. Mice were released from the restraint, and returned to
their cage for sleep-wakefulness recordings.
Statistical Analysis
Data are presented as mean ± SEM and were analyzed by
one-way ANOVA followed by post hoc analysis of significance
by Fisher’s Protected Least Significant Difference test or paired
t-test using the GraphPad Prism6 software package (GraphPad
Software).
RESULTS
Generation of Mice Lacking 5HT1A
Receptors Exclusively in Orexin Neurons
To decipher the physiological role of serotonergic regulation
of orexin neurons, we examined the phenotype of mice in
which orexin neurons selectively lack expression of 5HT1AR, a
sole subtype of serotonin receptor in orexin neurons (Muraki
et al., 2004). To generate these mice, we first made mice in
which the coding region of the gene encoding 5HT1AR (Htr1a)
is flanked by two loxP sites (Htr1a f /f mice). Since Htr1a
has a single exon, we introduced two loxP sites in regions
corresponding to the 3′- and 5′-non-coding regions in exon 1
of this gene so that two loxP sequences flank the coding region
(Figure 1A).
To obtain mice with a deletion of Htr1a restricted to
orexin-producing neurons, we mated Htr1a f /f mice with
orexin-Cre transgenic mice (Matsuki et al., 2009), in which
orexin neurons specifically express Cre recombinase, and
obtained ox5HT1ARKO mice (Htr1a f /f ;orexin-Cre mice).
Double immunofluorescence studies in wild-type control mice
showed that many neurons in the LH possessed 5HT1AR-like
immunoreactivity (ir) in their soma and dendrites (Figure 1B).
Among these, most orexin-ir cells (orexin-neurons) were positive
for 5HT1AR-ir, consistent with our previous observation that
all orexin neurons examined showed 5HT1AR-ir and strong
hyperpolarization when administered 5-HT (Muraki et al., 2004).
Similarly, we also observed that all orexin neurons in Htr1af /f
mice (Cre-negative) expressed 5HT1AR-ir in their soma and
dendrites (Figure 1B). In stark contrast, neurons positive for
both 5HT1AR-ir and orexin-ir were barely detectable in the
brain of ox5HT1ARKO mice, although we observed many
5HT1AR-ir-positive neurons in the LHA that were negative
for orexin (Figure 1B). Less than 10% of orexin neurons in
ox5HT1ARKO mice were double-labeled for orexin and 5HT1AR
(Figure 1B). The remaining expression of 5HT1AR in orexin
neurons may be due to incomplete penetrance of Cre expression
in orexin-Cre transgenic mice and/or incomplete deletion of
the gene fragment between loxP sites in ox5HT1ARKO mice.
These histological observations confirmed that in ox5HT1ARKO
mice, 92.3 ± 8% (n = 5) of orexin neurons lack expression of
5HT1AR.
Gross anatomical and histological studies failed to detect any
structural abnormalities in the brain of ox5HT1ARKO mice.
Specifically, the number of orexin neurons in the LH remained
normal; the number of immunoreactive cells (located from
0.76 mm to 2.52 mm posterior to the bregma) was 3,424 ± 154
and 3,462 ± 68 for control littermates and ox5HT1ARKO mice,
respectively (n = 8 each).
Figure 1C shows expression of 5HT1ARs in the raphe nuclei
in ox5HT1ARKO and control mice. Expression of 5HT1AR in
these regions in ox5HT1ARKO mice was indistinguishable from
that in transgene-negative Htr1a f /f controls, further supporting
that 5HT1AR remained intact in other neurons in ox5HT1ARKO
mice.
Electrophysiological Characteristics of
Orexin Neurons Lacking 5HT1A
Receptors
We next examined responses of orexin neurons to 5-HT by
whole cell patch-clamp recording using brain slice preparations
from ox5HT1ARKO and control mice (Figure 2). To make
identification of orexin neurons easier, we used ox5HT1ARKO
and control mice possessing the orexin-eGFP transgene
(Yamanaka et al., 2003). Bath application of 5-HT produced
potent, dose-dependent hyperpolarization in all orexin neurons
in wild type and control (Htr1af /f , orexin-Cre negative) mice,
consistent with our previous report (Muraki et al., 2004)
(Figures 2A–C). These 5-HT-induced inhibitory effects rapidly
reversed upon removal of 5-HT from the external solution
(Figure 2A). 5-HT failed to induce hyperpolarization in most
orexin neurons in ox5HT1ARKO mice (Figure 2B). Very
faint hyperpolarization was observed in four out of 19 orexin
neurons tested in slices from eight ox5HT1ARKO mice, while
we observed strong 5-HT-induced hyperpolarization in all
neurons examined in wild type and control mice. 5-HT induced
a less potent hyperpolarizing effect on orexin neurons of hetero
Htr1af /+;orexin-Cre (ox5HT1ARHKO) mice as compared with
controls, suggesting that the number of 5HT1ARs in these
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FIGURE 2 | Lack of functional 5HT1A receptors in orexin neurons of
ox5HT1ARKO mice. (A, upper) Representative trace showing the
hyperpolarizing effect of 5-HT (10 mM) on orexin neurons in a slice preparation
from a control mouse (5HT1ARf/f mouse without Cre expression) in a
current-clamp recording. Drugs were applied during the periods indicated by
bars. (A, lower) Representative trace showing the effect of 5-HT (10 mM) on
orexin neurons in ox5HT1ARKO slice. 5-HT does not induce any response,
but GABA (10 mM) induces a strong inhibitory response in the same neuron,
showing the neuron is viable. (B) Hyperpolarization of orexin neurons from
mice with various genotypes, induced by 5-HT (10 mM). WT, wild type;
5HT1ARf/f , Htr1af/f (orexin-Cre-negative); ox5HT1ARHKO, Htr1af/+ (hetero)
mice (orexin-Cre transgene-positive); ox5HT1ARKO, Htr1af/f mice with
orexin-Cre transgene. (C) Dose–response curves of 5-HT-induced
hyperpolarization of orexin neurons prepared from mice with various
genotypes. Horizontal axis show -log dose of 5HT.
ox5HT1ARHKO mice is lower than that in wild type mice, due
to haploinsufficiency (Figure 2C).
Orexin neurons lacking 5HT1AR showed a resting
membrane potential similar to that of orexin neurons in
control littermates (ox5HT1ARKO, −42.2 ± 3.2 mV, n = 19;
control,−42.3± 2.7 mV, n = 12, p = 0.98).
ox5HT1ARKO Mice Exhibited Decreased
Wakefulness Time in Later Phase of Dark
Period
Sleep/wakefulness state patterns of ox5HT1ARKO mice,
ox5HT1ARHKO mice, control littermate mice (Htr1af /f mice,
negative for Cre) and wild type mice were examined by
EEG/EMG recording. We found that the total wakefulness
time was significantly shorter and NREM sleep was longer
in ox5HT1ARKO mice than in control mice in the latter
half of the dark period (Figure 3 and Table 1). We did
not find any difference in episode duration of each state in
ox5HT1ARKO mice as compared with any other genotypes
FIGURE 3 | Sleep/wakefulness state patterns of ox5HT1ARKO,
ox5HT1ARHKO and control littermate mice (Htr1af/f mice, negative for Cre)
were examined by simultaneous EEG/EMG recordings. Total time of
wakefulness (WAKE) (A), NREM sleep (B) and REM sleep (C) in 2-h periods.
∗p < 0.05, ∗∗p < 0.01, significantly different from control mice. Bonferroni test
after two-way ANOVA.
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(Table 1). Neither direct transitions from wakefulness to
REM sleep nor cataplexy-like behavioral arrests, which are
characteristics of orexin-deficient narcoleptic mice, were
observed in ox5HT1ARKO mice. The ox5HT1ARKO mice show
comparable power spectral profiles of EEG with controls during
both NREM and REM sleep (Supplementary Figure S1).
5HT1A Receptors in Orexin Neurons Play
an Important Role in Homeostatic
Regulation of REM Sleep After Exposure
to Acute Stress
Physical stress has been shown to influence the sleep architecture
in rats, and especially lead to alteration of the REM sleep structure
mediated by serotonergic mechanisms (Rampin et al., 1991).
Orexin neurons were shown to be activated by stress (Chang
et al., 2007), and orexins potently inhibit REM sleep (Mieda
et al., 2011). These observations suggest the possibility that
the 5HTDR → orexin pathway plays a role in stress-induced
alterations in REM sleep architecture. To evaluate this hypothesis,
we applied a restraint stress to ox5HT1ARKO and control mice to
observe alterations in the sleep architecture. Mice were subjected
to mild restraint with nylon mesh for 30 or 90 min just before the
onset of the dark period, and subjected to sleep recording. Both
control mice and ox5HT1AKO mice showed a similar tendency
for an increase in NREM sleep amount during the dark period
after release from 30- or 90-min restraint stress, which is likely
to be attributable to sleep deprivation during stress application.
However, the stress did not alter the amount of REM sleep in
control mice, while ox5HT1ARKO mice responded by an increase
in REM sleep amount as compared with the basal condition
(Figure 4A). This change was due to an increase in the number
of REM sleep episodes, and not to lengthening of REM sleep
duration (Figure 4B). ox5HT1ARKO mice had a tendency for
decreased REM sleep time during the dark period in the basal
condition (Figure 3C), but after applying stress, they exhibited
a similar amount of REM sleep as compared with control mice.
Altogether, these data show that ox5HT1ARKO mice exhibited
augmented REM sleep enhancement responses to acute physical
stress.
DISCUSSION
Orexin neurons play highly important roles in the maintenance
of sleep/wakefulness states (Sakurai, 2007). The regulatory
mechanisms of orexin neurons have been examined by
many electrophysiological studies in vitro, and many factors
that can modulate the activity of these neurons have been
identified. However, the physiological relevance of the regulatory
mechanisms or inputs affecting the activity of orexin neurons
remains largely unknown. In our previous study, we examined
the phenotypes of mice in which GABAB receptors were
selectively removed in orexin neurons (Matsuki et al., 2009).
These mice showed highly fragmented sleep/wakefulness states
during both the dark and light periods, suggesting the importance
of GABA-mediated control of orexin neurons in physiological
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FIGURE 4 | Stress-induced alteration of REM sleep architecture is more prominent in ox5HT1ARKO mice as compared with controls (Htr1a f/f ). (A) Effects of 30-min
and 90-min mild restraint stress (RS 30, RS 90) in control mice and ox5HT1ARKO mice. RS was applied just before the onset of the dark period. (B) Amount,
duration and episode number of REM sleep during 12-h dark period after application of RS. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, significantly different from CC
(control conditions). Bonferroni test after two-way ANOVA.
sleep/wakefulness regulation. Here, we addressed the importance
of 5-HT-mediated inhibitory regulation of orexin neurons, since
we found 5-HT shows a very potent inhibitory effect on almost
all orexin neurons, and 5-HT also plays an important role
in the regulation of sleep/wakefulness states. Firing rates of
serotonergic neurons are lower during NREM sleep than during
wakefulness and lowest during REM sleep, displaying a similar
firing pattern to that of orexin neurons across sleep/wakefulness
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states (Lee et al., 2005; Mileykovskiy et al., 2005; Takahashi
et al., 2008). Orexin neurons send excitatory innervation to
serotonergic neurons in the raphe nuclei, which abundantly
express both OX1R and OX2R (Brown et al., 2002; Liu et al., 2002;
Kohlmeier et al., 2013), suggesting that activity of serotonergic
neurons is partly regulated by orexin neurons, and this function
was shown to be important for inhibition of cataplexy in
narcoleptic mice (Mieda et al., 2011; Hasegawa et al., 2017).
Direct serotonergic input to orexin neurons might tonically
inhibit orexin neurons during wakefulness states, constituting
negative feedback regulation. We also confirmed that optogenetic
activation of serotonergic fibers in the LH inhibited orexin
neurons in vitro (Saito et al., 2018). Although chemogenetic
activation of 5-HT neurons in the DR showed minimal effects
on activity of orexin neurons in vivo (Saito et al., 2018),
the physiological relevance of direct serotonergic influences on
orexin neurons in the regulation of sleep/wakefulness states has
been unclear.
Here, we made mice in which orexin neurons selectively lack
5HT1AR, the sole subtype of serotonin receptors expressed in
orexin neurons (ox5HT1ARKO mice) (Figure 1). ox5HT1ARKO
mice showed decreased wakefulness time and increased NREM
sleep time in the dark period, especially in the later half, as
compared with control mice, suggesting that these mice suffer
from hypersomnolence. This observation suggests that 5HT1AR-
mediated regulation of orexin neurons plays a role in sleep
regulation.
Initially, we hypothesized that deletion of serotonergic input
to orexin neurons by disrupting the Htr1a gene would results
in increased wakefulness, because 5-HT strongly inhibits orexin
neurons. However, orexin neurons receive complex regulation
by the serotonergic system. 5-HT neurons directly inhibit orexin
neurons, but indirectly disinhibit these cells through inhibition
of GABAergic neurons in the ventrolateral preoptic area (VLPO)
that send innervation to orexin neurons (Saito et al., 2018).
Therefore, total 5-HT output might have a net excitatory effect
on orexin neurons. However, contrary to our initial hypothesis,
ox5HT1ARKO mice showed increased NREM sleep time in
the later half of the dark period as compared with control
mice, suggesting that these mice suffer from hypersomnolence
(Figure 3). It has been shown that serotonergic tone peaked
in the earlier half of the dark period, but decreased in the
later half of the dark period in rats (Liu and Borjigin, 2006).
This suggests the possibility that decreased serotonergic activity
in the later half of the dark period results in a decrease in
5HT1AR-mediated inhibition of orexin neurons, leading to
activation of these cells to increase wakefulness. In accordance
with this hypothesis, wild type mice show a temporal increase in
wakefulness time during the later half of the dark period, which
peaks at CT7, but this increase was not observed in ox5HT1ARKO
mice (Figure 3B). This difference mainly contributes to the
decreased amount of wakefulness in ox5HT1ARKO mice as
compared with control mice. In addition, chronic deficiency of
5HT1AR-mediated inhibition of orexin neurons might result in
plastic changes of GABAergic/glutamatergic regulations of orexin
neurons. Compensatory increase in GABAergic input and/or
decrease in glutamatergic input to orexin neurons might play
a role in maintaining wakefulness amount within normal range
in the earlier phase of the dark period, but this change might
simultaneously decease the activity of these cells in the later half
of the dark period, when serotonergic tone is decreased.
The phenotype of ox5HT1ARKO mice demonstrates the
importance of serotonergic activity within a defined neuronal
circuit; in particular, that expression of these 5HT1ARs in
orexin neurons is necessary for appropriate maintenance of
wakefulness especially during the later half of the dark period.
It was shown that overexpression of 5HT1AR in mice rather
affected sleep/wakefulness states in the earlier half of the dark
period, with fragmentation of sleep/wakefulness (Tabuchi et al.,
2014). This also suggests the possibility that the serotonergic
influence on orexin neurons is maximal in the earlier half of
the dark period, while a decrease in serotonergic influence rather
disinhibits orexin neurons to support wakefulness.
We also examined the effect of acute stress on
sleep/wakefulness states in ox5HT1ARKO mice, because
stress might affect serotonergic regulation of orexin neurons.
ox5HT1ARKO mice showed greater REM sleep rebound
after release from restraint, as compared with wild type mice
(Figure 4). This result suggests that serotonergic regulation
of orexin neurons plays an important role in REM sleep
homeostasis. These results suggest the possibility that stress
activates orexin neurons, leading to transient activation of 5-HT
neurons. Orexin neurons might be disinhibited by decreased
serotonergic tone after release from stress, to inhibit REM sleep
in wild type mice. REM was gradually increased after the release
from the stress, peaking at 8 h after the stress, suggesting that
DR serotonergic activity might gradually decrease after the stress
over several hours.
This study also provides an insight into the mechanism
by which drugs influencing serotonergic tone act on sleep
physiology. Compounds such as SSRIs and anti-depressants may
increase serotonergic tone in orexin neurons, which could affect
sleep/wakefulness states at least partly through dysregulation of
orexin neurons. Furthermore, this study suggests that decreased
serotonergic influence on orexin neurons might be one of
the possible mechanisms of sleep disturbance in patients with
depression.
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ANOVA.
REFERENCES
Brown, R. E., Sergeeva, O. A., Eriksson, K. S., and Haas, H. L. (2002). Convergent
excitation of dorsal raphe serotonin neurons by multiple arousal systems
(orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 22, 8850–8859.
doi: 10.1523/JNEUROSCI.22-20-08850.2002
Chang, H., Saito, T., Ohiwa, N., Tateoka, M., Deocaris, C. C., Fujikawa, T., et al.
(2007). Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and
stress-induced ACTH responses in conscious rats. Neurosci. Res. 57, 462–466.
doi: 10.1016/j.neures.2006.11.009
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C.,
et al. (1999). Narcolepsy in orexin knockout mice: molecular genetics of sleep
regulation. Cell 98, 437–451. doi: 10.1016/S0092-8674(00)81973-X
Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., et al.
(1999). Orexins, orexigenic hypothalamic peptides, interact with autonomic,
neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96,
748–753. doi: 10.1073/pnas.96.2.748
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M.,
et al. (2001). Genetic ablation of orexin neurons in mice results in narcolepsy,
hypophagia, and obesity. Neuron 30, 345–354. doi: 10.1016/S0896-6273(01)
00293-8
Hasegawa, E., Maejima, T., Yoshida, T., Masseck, O. A., Herlitze, S., Yoshioka, M.,
et al. (2017). Serotonin neurons in the dorsal raphe mediate the anticataplectic
action of orexin neurons by reducing amygdala activity. Proc. Natl. Acad. Sci.
U.S.A. 114, E3526–E3535. doi: 10.1073/pnas.1614552114
Kohlmeier, K. A., Tyler, C. J., Kalogiannis, M., Ishibashi, M., Kristensen, M. P.,
Gumenchuk, I., et al. (2013). Differential actions of orexin receptors in
brainstem cholinergic and monoaminergic neurons revealed by receptor
knockouts: implications for orexinergic signaling in arousal and narcolepsy.
Front. Neurosci. 7:246. doi: 10.3389/fnins.2013.00246
Lee, M. G., Hassani, O. K., and Jones, B. E. (2005). Discharge of identified
orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25, 6716–
6720. doi: 10.1523/JNEUROSCI.1887-05.2005
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., et al. (1999). The
sleep disorder canine narcolepsy is caused by a mutation in the hypocretin
(orexin) receptor 2 gene. Cell 98, 365–376. doi: 10.1016/S0092-8674(00)
81965-0
Liu, R.-J., van den Pol, A. N., and Aghajanian, G. K. (2002). Hypocretins (orexins)
regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct
and inhibitory indirect actions. J. Neurosci. 22, 9453–9464. doi: 10.1523/
JNEUROSCI.22-21-09453.2002
Liu, T., and Borjigin, J. (2006). Relationship between nocturnal serotonin surge
and melatonin onset in rodent pineal gland. J. Circadian Rhythms 4:12.
doi: 10.1186/1740-3391-4-12
Matsuki, T., Nomiyama, M., Takahira, H., Hirashima, N., Kunita, S., Takahashi, S.,
et al. (2009). Selective loss of GABAB receptors in orexin-producing neurons
results in disrupted sleep/wakefulness architecture. Proc. Natl. Acad. Sci. U.S.A.
106, 4459–4464. doi: 10.1073/pnas.0811126106
Mieda, M., Hasegawa, E., Kisanuki, Y. Y., Sinton, C. M., Yanagisawa, M., and
Sakurai, T. (2011). Differential roles of orexin receptor-1 and -2 in the
regulation of non-REM and REM sleep. J. Neurosci. 31, 6518–6526. doi: 10.
1523/JNEUROSCI.6506-10.2011
Mileykovskiy, B. Y., Kiyashchenko, L. I., and Siegel, J. M. (2005). Behavioral
correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787–
798. doi: 10.1016/j.neuron.2005.04.035
Muraki, Y., Yamanaka, A., Tsujino, N., Kilduff, T. S., Goto, K., and Sakurai, T.
(2004). Serotonergic regulation of the orexin/hypocretin neurons through the
5-HT1A receptor. J. Neurosci. 24, 7159–7166. doi: 10.1523/JNEUROSCI.1027-
04.2004
Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K.
(1999). Distribution of orexin neurons in the adult rat brain. Brain Res. 827,
243–260. doi: 10.1016/S0006-8993(99)01336-0
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe,
J. G., et al. (1998). Neurons containing hypocretin (orexin) project to multiple
neuronal systems. J. Neurosci. 18, 9996–10015. doi: 10.1523/JNEUROSCI.18-
23-09996.1998
Pollak Dorocic, I., Fürth, D., Xuan, Y., Johansson, Y., Pozzi, L., Silberberg, G., et al.
(2014). A whole-brain atlas of inputs to serotonergic neurons of the dorsal and
median raphe nuclei. Neuron 83, 663–678. doi: 10.1016/j.neuron.2014.07.002
Rampin, C., Cespuglio, R., Chastrette, N., and Jouvet, M. (1991). Immobilisation
stress induces a paradoxical sleep rebound in rat. Neurosci. Lett. 126, 113–118.
doi: 10.1016/0304-3940(91)90532-X
Saito, Y. C., Maejima, T., Nishitani, M., Hasegawa, E., Yanagawa, Y., Mieda, M.,
et al. (2018). Monoamines inhibit GABAergic neurons in ventrolateral preoptic
area that make direct synaptic connections to hypothalamic arousal neurons.
J. Neurosci. 38, 6366–6378. doi: 10.1523/JNEUROSCI.2835-17.2018
Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep and
wakefulness. Nat. Rev. Neurosci. 8, 171–181. doi: 10.1038/nrn2092
Sakurai, T. (2014). The role of orexin in motivated behaviours. Nat. Rev. Neurosci.
15, 719–731. doi: 10.1038/nrn3837
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., et al.
(1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides
and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–
585. doi: 10.1016/S0092-8674(00)80949-6
Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., et al.
(2005). Input of orexin/hypocretin neurons revealed by a genetically encoded
tracer in mice. Neuron 46, 297–308. doi: 10.1016/j.neuron.2005.03.010
Soya, S., Takahashi, T. M., McHugh, T. J., Maejima, T., Herlitze, S., Abe, M.,
et al. (2017). Orexin modulates behavioral fear expression through the locus
coeruleus. Nat. Commun. 8:1606. doi: 10.1038/s41467-017-01782-z
Tabuchi, S., Tsunematsu, T., Black, S. W., Tominaga, M., Maruyama, M., Takagi, K.,
et al. (2014). Conditional ablation of orexin/hypocretin neurons: a new mouse
model for the study of narcolepsy and orexin system function. J. Neurosci. 34,
6495–6509. doi: 10.1523/JNEUROSCI.0073-14.2014
Takahashi, K., Lin, J.-S., and Sakai, K. (2008). Neuronal activity of orexin and
non-orexin waking-active neurons during wake-sleep states in the mouse.
Neuroscience 153, 860–870. doi: 10.1016/j.neuroscience.2008.02.058
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S.,
Aldrich, M., et al. (2000). Reduced number of hypocretin neurons in human
narcolepsy. Neuron 27, 469–474. doi: 10.1016/S0896-6273(00)00058-1
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M.,
et al. (2003). Hypothalamic orexin neurons regulate arousal according to energy
balance in mice. Neuron 38, 701–713. doi: 10.1016/S0896-6273(03)00331-3
Yoshida, K., McCormack, S., España, R. A., Crocker, A., and Scammell, T. E. (2006).
Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845–861.
doi: 10.1002/cne.20859
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Saito, Tsujino, Abe, Yamazaki, Sakimura and Sakurai. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Neuroscience | www.frontiersin.org 9 November 2018 | Volume 12 | Article 892
